In The Lancet Diabetes & Endocrinology, Jing Luo and colleagues present the HumAn-1 trial, an important contribution to the literature on type 1 diabetes in low-income and middle-income countries ...
As organizations operate with tighter budgets and rising pressure to adapt, many continue to invest heavily in education benefits, yet struggle to see the impact or ROI of these benefits—or even worse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results